Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.48
+0.03 (0.40%)
Feb 21, 2025, 4:00 PM EST - Market closed
Profound Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Profound Medical stock have an average target of 11.4, with a low estimate of 10.8 and a high estimate of 12. The average target predicts an increase of 52.41% from the current stock price of 7.48.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 16, 2024.
Analyst Ratings
The average analyst rating for Profound Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Hold → Strong Buy Upgrades $9 → $12 | Hold → Strong Buy | Upgrades | $9 → $12 | +60.43% | Jul 16, 2024 |
Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +44.39% | Mar 11, 2024 |
Stifel | Stifel | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +20.32% | Mar 8, 2024 |
Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +70.45% | Jan 4, 2024 |
Stifel | Stifel | Hold Initiates $11 | Hold | Initiates | $11 | +47.06% | Nov 28, 2023 |
Financial Forecast
Revenue This Year
11.27M
from 7.20M
Increased by 56.56%
Revenue Next Year
28.33M
from 11.27M
Increased by 151.33%
EPS This Year
-1.20
from -1.35
EPS Next Year
-0.91
from -1.20
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 11.8M | 42.0M | 82.1M | |||
Avg | 11.3M | 28.3M | 55.8M | |||
Low | 10.8M | 16.1M | 32.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 63.9% | 272.6% | 189.9% | |||
Avg | 56.6% | 151.3% | 96.9% | |||
Low | 49.7% | 42.6% | 14.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.02 | -0.22 | -0.15 | |||
Avg | -1.20 | -0.91 | -0.71 | |||
Low | -1.28 | -1.39 | -1.34 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.